Wealth Enhancement Advisory Services, LLC Cardiol Therapeutics Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 16,552 shares of CRDL stock, worth $16,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,552
Previous 16,770
1.3%
Holding current value
$16,883
Previous $17,000
5.88%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRDL
# of Institutions
53Shares Held
7.39MCall Options Held
25KPut Options Held
0-
Tejara Capital LTD London, X02.63MShares$2.68 Million1.47% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD557KShares$568,5350.11% of portfolio
-
Bank Of America Corp Charlotte, NC551KShares$562,0740.0% of portfolio
-
Marshall Wace, LLP London, X0544KShares$555,2030.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il463KShares$472,7310.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $63.2M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...